Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk.

Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, Sealock J, Karlsson IK, Hägg S, Athanasiu L, Voyle N, Proitsi P, Witoelar A, Stringer S, Aarsland D, Almdahl IS, Andersen F, Bergh S, Bettella F, Bjornsson S, Brækhus A, Bråthen G, de Leeuw C, Desikan RS, Djurovic S, Dumitrescu L, Fladby T, Hohman TJ, Jonsson PV, Kiddle SJ, Rongve A, Saltvedt I, Sando SB, Selbæk G, Shoai M, Skene NG, Snaedal J, Stordal E, Ulstein ID, Wang Y, White LR, Hardy J, Hjerling-Leffler J, Sullivan PF, van der Flier WM, Dobson R, Davis LK, Stefansson H, Stefansson K, Pedersen NL, Ripke S, Andreassen OA, Posthuma D.

Nat Genet. 2019 Jan 7. doi: 10.1038/s41588-018-0311-9. [Epub ahead of print]

PMID:
30617256
2.

Military-related experiences and late-life depressive symptomatology among Japanese-American world war II veterans.

Schaper KM, Mackintosh MA, Willis EA, Liu C, White LR.

Aging Ment Health. 2019 Jan 1:1-9. doi: 10.1080/13607863.2018.1558173. [Epub ahead of print]

PMID:
30599089
3.

Association of brain heptachlor epoxide and other organochlorine compounds with lewy pathology.

Ross GW, Abbott RD, Petrovitch H, Duda JE, Tanner CM, Zarow C, Uyehara-Lock JH, Masaki KH, Launer LJ, Studabaker WB, White LR.

Mov Disord. 2018 Dec 30. doi: 10.1002/mds.27594. [Epub ahead of print]

PMID:
30597605
4.

Meta-analysis of Alzheimer's disease on 9,751 samples from Norway and IGAP study identifies four risk loci.

Witoelar A, Rongve A, Almdahl IS, Ulstein ID, Engvig A, White LR, Selbæk G, Stordal E, Andersen F, Brækhus A, Saltvedt I, Engedal K, Hughes T, Bergh S, Bråthen G, Bogdanovic N, Bettella F, Wang Y, Athanasiu L, Bahrami S, Le Hellard S, Giddaluru S, Dale AM, Sando SB, Steinberg S, Stefansson H, Snaedal J, Desikan RS, Stefansson K, Aarsland D, Djurovic S, Fladby T, Andreassen OA.

Sci Rep. 2018 Dec 27;8(1):18088. doi: 10.1038/s41598-018-36429-6.

5.

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.

Twohig D, Rodriguez-Vieitez E, Sando SB, Berge G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, Patra K, Bu G, Benzinger TLS, Karch CM, Fagan A, Morris JC, Bateman RJ, Nordberg A, White LR, Nielsen HM; Dominantly Inherited Alzheimer Network (DIAN).

Acta Neuropathol Commun. 2018 Nov 26;6(1):130. doi: 10.1186/s40478-018-0624-z.

6.

TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Flanagan ME, Cholerton B, Latimer CS, Hemmy LS, Edland SD, Montine KS, White LR, Montine TJ.

J Alzheimers Dis. 2018;66(4):1549-1558. doi: 10.3233/JAD-180162.

PMID:
30452409
7.

Association between cytokines and psychiatric symptoms in chronic fatigue syndrome and healthy controls.

Groven N, Fors EA, Iversen VC, White LR, Reitan SK.

Nord J Psychiatry. 2018 Nov;72(8):556-560. doi: 10.1080/08039488.2018.1493747. Epub 2018 Jul 31.

PMID:
30063870
8.

Effects of Military Service on Marital Stability Among World War II U.S. Veterans of Japanese Descent.

Mackintosh MA, Schaper KM, Willis EA, Edland S, Liu C, White LR.

Mil Med. 2018 Jun 23. doi: 10.1093/milmed/usy091. [Epub ahead of print]

PMID:
29939363
9.

Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease.

Patra K, Soosaipillai A, Sando SB, Lauridsen C, Berge G, Møller I, Grøntvedt GR, Bråthen G, Begcevic I, Moussaud S, Minthon L, Hansson O, Diamandis EP, White LR, Nielsen HM.

Alzheimers Res Ther. 2018 Jan 29;10(1):9. doi: 10.1186/s13195-018-0336-4.

10.

Convective and diffusive effects on particle transport in asymmetric periodic capillaries.

Islam N, Miklavcic SJ, Bradshaw-Hajek BH, White LR.

PLoS One. 2017 Aug 25;12(8):e0183127. doi: 10.1371/journal.pone.0183127. eCollection 2017.

11.

Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.

Lauridsen C, Sando SB, Møller I, Berge G, Pomary PK, Grøntvedt GR, Salvesen Ø, Bråthen G, White LR.

Front Aging Neurosci. 2017 Jun 28;9:210. doi: 10.3389/fnagi.2017.00210. eCollection 2017.

12.

Marinesco bodies and substantia nigra neuron density in Parkinson's disease.

Abbott RD, Nelson JS, Ross GW, Uyehara-Lock JH, Tanner CM, Masaki KH, Launer LJ, White LR, Petrovitch H.

Neuropathol Appl Neurobiol. 2017 Dec;43(7):621-630. doi: 10.1111/nan.12419. Epub 2017 Jul 9.

13.

Resistance to Alzheimer Disease Neuropathologic Changes and Apparent Cognitive Resilience in the Nun and Honolulu-Asia Aging Studies.

Latimer CS, Keene CD, Flanagan ME, Hemmy LS, Lim KO, White LR, Montine KS, Montine TJ.

J Neuropathol Exp Neurol. 2017 Jun 1;76(6):458-466. doi: 10.1093/jnen/nlx030.

14.

A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imaging.

Mo Y, Stromswold J, Wilson K, Holder D, Sur C, Laterza O, Savage MJ, Struyk A, Scheltens P, Teunissen CE, Burke J, Macaulay SL, Bråthen G, Sando SB, White LR, Weiss C, Cowes A, Bush MM, DeSilva G, Darby DG, Rainey-Smith SR, Surls J, Sagini E, Tanen M, Altman A, Luthman J, Egan MF.

Alzheimers Dement (Amst). 2017 Mar 6;6:201-209. doi: 10.1016/j.dadm.2017.02.004. eCollection 2017.

15.

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.

Almdahl IS, Lauridsen C, Selnes P, Kalheim LF, Coello C, Gajdzik B, Møller I, Wettergreen M, Grambaite R, Bjørnerud A, Bråthen G, Sando SB, White LR, Fladby T.

Front Aging Neurosci. 2017 Feb 7;9:9. doi: 10.3389/fnagi.2017.00009. eCollection 2017.

16.

Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.

Rueli RH, Torres DJ, Dewing AS, Kiyohara AC, Barayuga SM, Bellinger MT, Uyehara-Lock JH, White LR, Moreira PI, Berry MJ, Perry G, Bellinger FP.

J Alzheimers Dis. 2017;55(2):749-762.

17.

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer's disease, mild cognitive impairment, or healthy controls: a two year follow-up study.

Berge G, Sando SB, Albrektsen G, Lauridsen C, Møller I, Grøntvedt GR, Bråthen G, White LR.

BMC Neurol. 2016 Sep 21;16(1):180.

18.

Changes in Frailty Predict Changes in Cognition in Older Men: The Honolulu-Asia Aging Study.

Armstrong JJ, Godin J, Launer LJ, White LR, Mitnitski A, Rockwood K, Andrew MK.

J Alzheimers Dis. 2016 Jun 15;53(3):1003-13. doi: 10.3233/JAD-151172.

19.

JC Virus Infects Neurons and Glial Cells in the Hippocampus.

Wüthrich C, Batson S, Anderson MP, White LR, Koralnik IJ.

J Neuropathol Exp Neurol. 2016 Jun 12. pii: nlw050. [Epub ahead of print]

20.

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.

Lauridsen C, Sando SB, Shabnam A, Møller I, Berge G, Grøntvedt GR, Bakken IJ, Salvesen Ø, Bråthen G, White LR.

Front Aging Neurosci. 2016 Mar 1;8:30. doi: 10.3389/fnagi.2016.00030. eCollection 2016.

21.

Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies.

White LR, Edland SD, Hemmy LS, Montine KS, Zarow C, Sonnen JA, Uyehara-Lock JH, Gelber RP, Ross GW, Petrovitch H, Masaki KH, Lim KO, Launer LJ, Montine TJ.

Neurology. 2016 Mar 15;86(11):1000-8. doi: 10.1212/WNL.0000000000002480. Epub 2016 Feb 17.

22.

Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.

Vijayaraghavan S, Darreh-Shori T, Rongve A, Berge G, Sando SB, White LR, Auestad BH, Witoelar A, Andreassen OA, Ulstein ID, Aarsland D.

J Alzheimers Dis. 2016;50(2):567-76. doi: 10.3233/JAD-150750.

PMID:
26757188
23.

Midlife milk consumption and substantia nigra neuron density at death.

Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, White LR, Tanner CM.

Neurology. 2016 Feb 9;86(6):512-9. doi: 10.1212/WNL.0000000000002254. Epub 2015 Dec 9.

24.

Phytoestrogen consumption and risk for cognitive decline and dementia: With consideration of thyroid status and other possible mediators.

Soni M, White LR, Kridawati A, Bandelow S, Hogervorst E.

J Steroid Biochem Mol Biol. 2016 Jun;160:67-77. doi: 10.1016/j.jsbmb.2015.10.024. Epub 2015 Nov 1. Review.

PMID:
26535810
25.

Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals.

Berge G, Lauridsen C, Sando SB, Holder DJ, Møller I, Aasly JO, Bråthen G, Savage MJ, White LR.

J Alzheimers Dis. 2016;49(2):493-502. doi: 10.3233/JAD-150234.

PMID:
26484901
26.

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy.

Aasly JO, Sæther O, Johansen KK, Bathen TF, Giskeødegård GF, White LR.

Parkinsons Dis. 2015;2015:264896. doi: 10.1155/2015/264896. Epub 2015 Aug 18.

27.

Clinical-pathologic correlations in vascular cognitive impairment and dementia.

Flanagan M, Larson EB, Latimer CS, Cholerton B, Crane PK, Montine KS, White LR, Keene CD, Montine TJ.

Biochim Biophys Acta. 2016 May;1862(5):945-51. doi: 10.1016/j.bbadis.2015.08.019. Epub 2015 Aug 28. Review.

28.

Cumulative impact of health deficits, social vulnerabilities, and protective factors on cognitive dynamics in late life: a multistate modeling approach.

Armstrong JJ, Mitnitski A, Andrew MK, Launer LJ, White LR, Rockwood K.

Alzheimers Res Ther. 2015 Jun 5;7(1):38. doi: 10.1186/s13195-015-0120-7. eCollection 2015.

29.

Rhabdomyomatous mesenchymal hamartoma of the face causing trigeminal neuralgia.

White LR Jr, Agrawal V, Sutton L, Balbosa AC.

Am J Case Rep. 2015 Jun 3;16:338-40. doi: 10.12659/AJCR.893719.

30.

Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.

Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, Chasman DI, McEvoy LK, Holland D, Chen CH, Karow DS, Brewer JB, Hess CP, Williams J, Sims R, O'Donovan MC, Choi SH, Bis JC, Ikram MA, Gudnason V, DeStefano AL, van der Lee SJ, Psaty BM, van Duijn CM, Launer L, Seshadri S, Pericak-Vance MA, Mayeux R, Haines JL, Farrer LA, Hardy J, Ulstein ID, Aarsland D, Fladby T, White LR, Sando SB, Rongve A, Witoelar A, Djurovic S, Hyman BT, Snaedal J, Steinberg S, Stefansson H, Stefansson K, Schellenberg GD, Andreassen OA, Dale AM; Inflammation working group, IGAP and DemGene Investigators.

Circulation. 2015 Jun 9;131(23):2061-2069. doi: 10.1161/CIRCULATIONAHA.115.015489. Epub 2015 Apr 10.

31.

Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease.

Steinberg S, Stefansson H, Jonsson T, Johannsdottir H, Ingason A, Helgason H, Sulem P, Magnusson OT, Gudjonsson SA, Unnsteinsdottir U, Kong A, Helisalmi S, Soininen H, Lah JJ; DemGene, Aarsland D, Fladby T, Ulstein ID, Djurovic S, Sando SB, White LR, Knudsen GP, Westlye LT, Selbæk G, Giegling I, Hampel H, Hiltunen M, Levey AI, Andreassen OA, Rujescu D, Jonsson PV, Bjornsson S, Snaedal J, Stefansson K.

Nat Genet. 2015 May;47(5):445-7. doi: 10.1038/ng.3246. Epub 2015 Mar 25.

PMID:
25807283
32.

Social vulnerability and survival across levels of frailty in the Honolulu-Asia Aging Study.

Armstrong JJ, Andrew MK, Mitnitski A, Launer LJ, White LR, Rockwood K.

Age Ageing. 2015 Jul;44(4):709-12. doi: 10.1093/ageing/afv016. Epub 2015 Mar 10.

33.

Associations of brain lesions at autopsy with polysomnography features before death.

Gelber RP, Redline S, Ross GW, Petrovitch H, Sonnen JA, Zarow C, Uyehara-Lock JH, Masaki KH, Launer LJ, White LR.

Neurology. 2015 Jan 20;84(3):296-303. doi: 10.1212/WNL.0000000000001163. Epub 2014 Dec 10.

34.

Increased selenoprotein P in choroid plexus and cerebrospinal fluid in Alzheimer's disease brain.

Rueli RH, Parubrub AC, Dewing AS, Hashimoto AC, Bellinger MT, Weeber EJ, Uyehara-Lock JH, White LR, Berry MJ, Bellinger FP.

J Alzheimers Dis. 2015;44(2):379-83. doi: 10.3233/JAD-141755.

35.

The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer's disease.

Kjelvik G, Saltvedt I, White LR, Stenumgård P, Sletvold O, Engedal K, Skåtun K, Lyngvær AK, Steffenach HA, Håberg AK.

BMC Neurol. 2014 Aug 26;14:168. doi: 10.1186/s12883-014-0168-1.

36.

Frailty in the Honolulu-Asia Aging Study: deficit accumulation in a male cohort followed to 90% mortality.

Armstrong JJ, Mitnitski A, Launer LJ, White LR, Rockwood K.

J Gerontol A Biol Sci Med Sci. 2015 Jan;70(1):125-31. doi: 10.1093/gerona/glu089. Epub 2014 Jun 27.

37.

Apolipoprotein E ε2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort.

Berge G, Sando SB, Rongve A, Aarsland D, White LR.

J Neurol Neurosurg Psychiatry. 2014 Nov;85(11):1227-31. doi: 10.1136/jnnp-2013-307228. Epub 2014 Mar 17.

38.

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destée A, Ferrarese C, Ferraris A, Fiske B, Gispert S, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lin CH, Lohmann K, Loriot MA, Lynch T, Mellick GD, Mutez E, Opala G, Park SS, Petrucci S, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Tomiyama H, Uitti RJ, Valente EM, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Xiromerisiou G, Maraganore DM, Farrer MJ, Ross OA; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Neurobiol Aging. 2014 Jan;35(1):266.e5-14. doi: 10.1016/j.neurobiolaging.2013.07.013. Epub 2013 Aug 17.

39.

Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Heckman MG, Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Boczarska-Jedynak M, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Petrucci S, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, Van Broeckhoven C, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Hentati F, Farrer MJ, Ross OA; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Mov Disord. 2013 Oct;28(12):1740-4. doi: 10.1002/mds.25600. Epub 2013 Aug 2.

40.

Antihypertensive medication use and risk of cognitive impairment: the Honolulu-Asia Aging Study.

Gelber RP, Ross GW, Petrovitch H, Masaki KH, Launer LJ, White LR.

Neurology. 2013 Sep 3;81(10):888-95. doi: 10.1212/WNL.0b013e3182a351d4. Epub 2013 Aug 2.

41.

IgM to S-nitrosylated protein is found intrathecally in relapsing-remitting multiple sclerosis.

Hvaring C, Vujicic S, Aasly JO, Feinstein DL, White LR, Boullerne AI.

J Neuroimmunol. 2013 Mar 15;256(1-2):77-83. doi: 10.1016/j.jneuroim.2012.12.011. Epub 2013 Jan 22.

PMID:
23351705
42.

Changes in selenoprotein P in substantia nigra and putamen in Parkinson's disease.

Bellinger FP, Raman AV, Rueli RH, Bellinger MT, Dewing AS, Seale LA, Andres MA, Uyehara-Lock JH, White LR, Ross GW, Berry MJ.

J Parkinsons Dis. 2012;2(2):115-26. doi: 10.3233/JPD-2012-11052.

43.

Brain organochlorines and Lewy pathology: the Honolulu-Asia Aging Study.

Ross GW, Duda JE, Abbott RD, Pellizzari E, Petrovitch H, Miller DB, O'Callaghan JP, Tanner CM, Noorigian JV, Masaki K, Launer L, White LR.

Mov Disord. 2012 Sep 15;27(11):1418-24. doi: 10.1002/mds.25144. Epub 2012 Sep 13.

44.

The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment.

Gelber RP, Launer LJ, White LR.

Curr Alzheimer Res. 2012 Jul;9(6):664-72.

45.

Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study.

Shah NS, Vidal JS, Masaki K, Petrovitch H, Ross GW, Tilley C, DeMattos RB, Tracy RP, White LR, Launer LJ.

Hypertension. 2012 Apr;59(4):780-6. doi: 10.1161/HYPERTENSIONAHA.111.178962. Epub 2012 Mar 5.

46.

Lifestyle and the risk of dementia in Japanese-american men.

Gelber RP, Petrovitch H, Masaki KH, Abbott RD, Ross GW, Launer LJ, White LR.

J Am Geriatr Soc. 2012 Jan;60(1):118-23. doi: 10.1111/j.1532-5415.2011.03768.x. Epub 2011 Dec 28.

47.

Pre-motor features of Parkinson's disease: the Honolulu-Asia Aging Study experience.

Ross GW, Abbott RD, Petrovitch H, Tanner CM, White LR.

Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S199-202. doi: 10.1016/S1353-8020(11)70062-1. Review.

PMID:
22166434
48.

Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study.

Launer LJ, Hughes TM, White LR.

Ann Neurol. 2011 Nov;70(5):774-80. doi: 10.1002/ana.22520.

49.

Evidence of important, common disease processes contributing to late-life dementia that have not yet been recognized, characterized, or even named.

White LR.

J Alzheimers Dis. 2012;28(2):481-3. doi: 10.3233/JAD-2011-111269. No abstract available.

PMID:
22045489
50.

Effect of disjoining pressure on terminal velocity of a bubble sliding along an inclined wall.

Del Castillo LA, Ohnishi S, White LR, Carnie SL, Horn RG.

J Colloid Interface Sci. 2011 Dec 15;364(2):505-11. doi: 10.1016/j.jcis.2011.08.046. Epub 2011 Aug 26.

Supplemental Content

Loading ...
Support Center